+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
EV-Based Liquid Biopsy Market - Global Forecast 2026-2032- Product Image
EV-Based Liquid Biopsy Market - Global Forecast 2026-2032- Product Image
New

EV-Based Liquid Biopsy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924680
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Extracellular vesicle (EV)-based liquid biopsy is redefining standards in oncology and chronic disease management by offering a minimally invasive approach to real-time molecular diagnostics. As precision medicine progresses, this technology is becoming instrumental for organizations seeking robust disease monitoring and targeted therapeutic oversight.

Market Snapshot: EV-Based Liquid Biopsy Market in Focus

The EV-Based Liquid Biopsy Market is positioned for robust advancement, with a notable rise in market value from 2025 to 2026 and strong, sustained growth expected through 2032. This momentum reflects increased demand for precise molecular insights and accelerated innovation across the vendor landscape. Healthcare providers, diagnostic developers, and life sciences partners are tapping into this market to address urgent needs for reliable, minimally invasive diagnostics in oncology and beyond. The evolution of clinical workflows and the expanding base of actionable biomarkers underpin ongoing adoption, as organizations invest in scalable platforms and specialized expertise to enhance patient outcomes and operational efficiency.

Scope & Segmentation of the EV-Based Liquid Biopsy Market

This comprehensive market analysis details essential segmentation and regional perspectives to support strategic business decisions and investment planning:

  • Product Types: Includes instruments and diagnostic platforms, such as flow cytometers, next-generation sequencing equipment, and qPCR devices; kits and reagents for isolating and detecting EVs; as well as analytical and sample preparation services tailored to high-throughput laboratory needs.
  • Technology Types: Covers core detection and analysis technologies, including ELISA methods, flow cytometry, microarray technologies, next-generation sequencing strategies, quantitative PCR, and nanoparticle-based assays, each enabling multi-analyte and multi-parameter profiling for granular insights.
  • Applications: Ranges from companion diagnostics and early cancer detection, to prognosis, longitudinal disease monitoring, and dedicated research applications, each demanding specific assay workflows and tailored validation strategies.
  • Disease Indications: Focuses on major cancers such as breast, colorectal, lung, and prostate, aligning developmental and commercialization priorities with regional healthcare needs and biomarker prevalence.
  • End Users: Spans diagnostic laboratories, clinical hospitals, pharmaceutical companies, and academic research centers, reflecting diverse workflow integration, regulatory compliance requirements, and adoption cycles.
  • Regional Coverage: Analysis incorporates Americas, Europe, Middle East and Africa, and Asia-Pacific markets, with discrete emphasis on regional regulatory, commercial, and clinical priorities driving strategic decisions.

Key Takeaways: Strategic Insights for Decision-Makers

  • Integrating EV-based liquid biopsy assays equips clinical laboratories with real-time capabilities for ongoing molecular patient monitoring and adaptive care pathways.
  • Innovations in EV isolation, sensitive signal detection, and multi-omic testing have markedly strengthened diagnostic assay quality and workflow harmonization, supporting consistent results across multiple sites.
  • Cooperation among manufacturers, assay developers, clinical consortia, and pharmaceutical sponsors is accelerating evidence collection and engagement with regulatory bodies, expediting product validation and approval processes.
  • Distinct commercialization models are emerging, with laboratories pivoting between bespoke tests and commercial kit or platform solutions based on institutional requirements and payer frameworks.
  • Regional dynamics drive unique adoption strategies: the Americas leverage advanced clinical and research networks, while Asia-Pacific sees rapid uptake due to expanded private health systems and increased investment in genomics infrastructure.
  • Attention to operational resilience—such as sourcing diversity, local production capacity, and modular design—is rising as organizations adapt to evolving global trade conditions and tariffs.

Tariff Impact: Operational and Supply Chain Shifts

Tariff policies introduced in 2025 have prompted diagnostic firms to rethink procurement and supply chain models. Organizations are actively diversifying suppliers, optimizing inventory strategies, and renegotiating contracts to offset the rising costs associated with imports. Adjustments range from redesigning product packaging and components to increased reliance on regional manufacturing, all aiming to increase operational flexibility and resilience in uncertain trade environments.

Methodology & Data Sources

This intelligence report leverages qualitative interviews with laboratory leaders, clinicians, and industry stakeholders, supplemented by in-depth secondary research from published literature, regulatory filings, clinical trial databases, and patent reviews. Data triangulation informs a nuanced understanding of developmental trends, operational barriers, and emerging commercial opportunities within the sector.

Why This Report Matters: Decision-Ready Value

  • Enables strategic leadership to guide procurement, partnerships, and product launches with data-driven segmentation and regional market intelligence focused on EV-based liquid biopsy solutions.
  • Equips commercial teams with actionable insights to meet end-user expectations, understand technology adoption patterns, and foresee regulatory or payer-driven changes affecting commercialization strategies.
  • Provides clear recommendations for navigating evolving global supply chains and regulatory environments, ensuring stakeholder readiness and market resilience in response to shifting external forces.

Conclusion

EV-based liquid biopsy represents a convergence of advanced science and practical diagnostic implementation. Organizations prioritizing reliable, collaborative, and adaptable solutions will be best placed to drive success and patient impact in this evolving healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. EV-Based Liquid Biopsy Market, by Product Type
8.1. Instruments And Platforms
8.1.1. Flow Cytometers
8.1.2. NGS Platforms
8.1.3. qPCR Instruments
8.2. Kits And Reagents
8.2.1. Detection Kits
8.2.2. Isolation Kits
8.2.3. Labeling Reagents
8.3. Services
8.3.1. Analytical Services
8.3.2. Sample Preparation Services
9. EV-Based Liquid Biopsy Market, by Technology
9.1. ELISA
9.2. Flow Cytometry
9.3. Microarray
9.4. Nanoparticle Assays
9.5. NGS
9.6. qPCR
10. EV-Based Liquid Biopsy Market, by Disease Indication
10.1. Breast Cancer
10.2. Colorectal Cancer
10.3. Lung Cancer
10.4. Prostate Cancer
11. EV-Based Liquid Biopsy Market, by Application
11.1. Companion Diagnostics
11.2. Early Cancer Detection
11.3. Prognosis And Monitoring
11.4. Research
12. EV-Based Liquid Biopsy Market, by End User
12.1. Diagnostic Laboratories
12.2. Hospitals And Clinics
12.3. Pharmaceutical Companies
12.4. Research Centers
13. EV-Based Liquid Biopsy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. EV-Based Liquid Biopsy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. EV-Based Liquid Biopsy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States EV-Based Liquid Biopsy Market
17. China EV-Based Liquid Biopsy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abcam PLC
18.6. Agena Bioscience
18.7. Agilent Technologies, Inc.
18.8. ALS Automated Lab Solutions GmbH
18.9. ANGLE PLC
18.10. Bio-Rad Laboratories, Inc
18.11. Bio-Techne Corporation
18.12. BioFluidica
18.13. Biological Dynamics
18.14. Bristol-Myers Squibb
18.15. C.H. Boehringer Sohn AG & Co. KG
18.16. Clinomics Europe Ltd.
18.17. Corning Incorporated
18.18. ExosomeDx
18.19. Horiba Ltd.
18.20. Illumina, Inc.
18.21. Lonza Group Ltd.
18.22. Malvern Panalytical Ltd.
18.23. Mercy BioAnalytics, Inc.
18.24. MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH
18.25. Mursla Bio
18.26. Nanostics Inc.
18.27. PerkinElmer, Inc.
18.28. Qiagen N.V.
18.29. Quest Diagnostics
18.30. System Biosciences, LLC
18.31. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 156. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 157. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 159. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 174. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 176. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 178. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASEAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 183. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 184. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 185. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 187. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. GCC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 201. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 202. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 203. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 205. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. BRICS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 210. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 211. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 212. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 214. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. G7 EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 219. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 220. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 221. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 223. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. NATO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2032 (USD MILLION)
TABLE 238. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 239. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 240. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 242. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this EV-Based Liquid Biopsy market report include:
  • Abcam PLC
  • Agena Bioscience
  • Agilent Technologies, Inc.
  • ALS Automated Lab Solutions GmbH
  • ANGLE PLC
  • Bio-Rad Laboratories, Inc
  • Bio-Techne Corporation
  • BioFluidica
  • Biological Dynamics
  • Bristol-Myers Squibb
  • C.H. Boehringer Sohn AG & Co. KG
  • Clinomics Europe Ltd.
  • Corning Incorporated
  • ExosomeDx
  • Horiba Ltd.
  • Illumina, Inc.
  • Lonza Group Ltd.
  • Malvern Panalytical Ltd.
  • Mercy BioAnalytics, Inc.
  • MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH
  • Mursla Bio
  • Nanostics Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • System Biosciences, LLC
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 641.81 Million
Forecasted Market Value ( USD ) by 2032 $ 1690 Million
Compound Annual Growth Rate17.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Liquid Biopsy Market - Global Forecast 2026-2032 - Product Image

Liquid Biopsy Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Liquid Biopsy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Liquid Biopsy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Competitive Landscape of Liquid Biopsy Market, Forecast by Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue - Product Image

Competitive Landscape of Liquid Biopsy Market, Forecast by Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue

  • Report
  • 200 Pages
  • Global
From

About the EV Based Liquid Biopsy Market

The EV Based Liquid Biopsy market is a rapidly growing segment of the pharmaceutical industry. It is a type of non-invasive diagnostic test that uses circulating cell-free extracellular vesicles (EVs) to detect and monitor cancer. EVs are released from cells into the bloodstream and can be used to detect cancer-specific biomarkers, providing a more accurate diagnosis than traditional methods. This technology has the potential to revolutionize cancer diagnosis and treatment, as it can detect cancer at an earlier stage and provide more precise information about the disease. EV Based Liquid Biopsy is also being used to monitor the effectiveness of cancer treatments, as well as to detect and monitor other diseases such as cardiovascular disease and neurological disorders. This technology is being used in clinical trials and is expected to become more widely available in the near future. Some companies in the EV Based Liquid Biopsy market include Exosome Diagnostics, Exosomics, Exosome Sciences, and Exosome Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.